Delivery Order SPE2DB24D8003-SPE2DB25FJTSJ

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,126.11, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Firm Fixed Price Delivery Order for the supply of JUNEL FE 1.5 MG-30 MCG TABLET 28S, a pharmaceutical product. The award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of JUNEL FE 1.5 MG-30 MCG TABLET 28S. The contract has a ceiling value of $2,213.22 and a period of performance through May 8, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $11,449.26 firm fixed-price delivery order is for the supply of pharmaceutical products, specifically LO LOESTRIN FE 1-10 tablets, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a small disadvantaged business. The contract, valued at $3,280.74, is for the supply of the pharmaceutical product JUNEL FE 1.5 MG-30 MCG TABLET 28S. The contract has a period of performance through May 24, 2024. Dakota Drug, Inc. is an experienced prime contractor that specializes in providing a wide range of pharmaceutical products, medical supplies,...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBRBT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc. The $1,643.04 delivery order contract is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. Dakota Drug, Inc. is a self-certified small disadvantaged business registered in SAM.gov, operating as a for-profit Subchapter S corporation. The company specializes in providing pharmaceutical products,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a small disadvantaged business. The contract, valued at $3,900.47, is for the delivery of Jardiance 10 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, to provide a comprehensive range of pharmaceutical products, medical supplies, and...
This is a federal contract award by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has an award value of $1,193.01 and a completion date of February 7, 2024. This award is not associated with a set-aside program and is a firm fixed-price delivery order contract. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $2,117.13, is for the delivery of the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S. The contract is a firm fixed-price delivery order and has an ultimate completion date of February 28, 2025. Dakota Drug, Inc. is a key supplier for the DLA, holding a significant single-award Indefinite Delivery Contract...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 90 tablets of the prescription medication Jardiance 10 mg. The contract has a ceiling value of $4,835.60 and a performance period that runs through October 17, 2024. The award is not associated with a set-aside program. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The award, valued at $3,964.31, is a delivery order under a larger Indefinite Delivery Contract (IDC) called SPE2DB24D8001, which has a ceiling value of $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V Program and allows Dakota...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJTSJ
    Delivery Order

This is a delivery order award to Dakota Drug, Inc., a self-certified small disadvantaged business, under the Defense Logistics Agency's (DLA) Troop Support Medical ECAT Generation V Program. The $1,468.56 firm fixed-price award is for the delivery of Junel FE 1.5 mg-30 mcg tablets to support U.S. Armed Forces medical operations. The award has an ultimate completion date of January 28, 2025. Dakota Drug, Inc. also holds a single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment. This award is not set aside.

Generated 4/28/25, 9:49 AM